Loading…
Loading…
Profound Medical Corp. (TSE: PRN - Get Free Report) insider Richard Ringler Fabian acquired 10,000 shares of the firm's stock in a transaction that occurred on Thursday, September 17th. The shares were bought at an average cost of C$8.31 per share, with a total value of C$83,100.00. Following the completion of the purchase, the insider owned
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Perion (NASDAQ & TASE: PERI), an advanced technology leader solving for the complexities of digital advertising through AI-native execution infrastructure, today announced it is accelerating its in-store media presence with the acquisition of PRN, a leading In-Store Retail Media company. The transaction amount is up to $12 million and is expected to be accretive from closing. Physical retail accounts for more than 80% of U.S. retail commerce, an.
If you're interested in broad exposure to the Industrials - Broad segment of the equity market, look no further than the Invesco Dorsey Wright Industrials Momentum ETF (PRN), a passively managed exchange traded fund launched on October 12, 2006.
AI infrastructure spending, strong defense demand, and rising manufacturing activity have all helped to push the industrials sector higher this year. The benchmark Industrial Select Sector SPDR Fund NYSEARCA: XLI, which tracks a broad index of large S&P companies in the industrials sector, has returned more than 16% year to date (YTD), making it one of the top-performing sector-specific funds over that period.
Launched on October 12, 2006, the Invesco Dorsey Wright Industrials Momentum ETF (PRN) is a passively managed exchange traded fund designed to provide a broad exposure to the Industrials - Broad segment of the equity market.
TORONTO, May 14, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (“iMRI”) procedures, is pleased to announce that the TULSA Procedure™ will be highlighted in four oral presentations at the upcoming American Urological Association's (“AUA”) Annual Meeting in Washington, DC, in the session titled “Prostate Cancer: Localized: Ablative Therapy II” on May 16th from 1:00-3:00 p.m. ET. TULSA Procedure Talks at AUA2026 Ram A.
Profound Medical Corp. (PRN:CA) Shareholder/Analyst Call Prepared Remarks Transcript
Profound Medical Corp. (PRN:CA) Q1 2026 Earnings Call Transcript